LOS ANGELES, Feb. 8, 2024 /PRNewswire/ -- AppliedVR®, a medical device pioneer advancing a novel, virtual reality-based approach to medicine, and Kernel today announced a joint study measuring the impact of VR pain treatment on the brain.

LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- AppliedVR®, an immersive therapeutics (ITx) pioneer advancing a novel, virtual reality-based approach to medicine, today announced results from a secondary analysis of a large randomized controlled trial (RCT) that evaluated how a virtual reality (VR) therapy to treat chronic low back pain (cLBP) at home affected patients who experience pain more intensely.

LOS ANGELES, July 20, 2023 /PRNewswire/ -- AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel approach to medicine, today announced interim analysis results of a phase 2 clinical trial study performed in collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

LOS ANGELES, Nov. 7, 2023 /PRNewswire/ -- AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel, virtual reality-based approach to medicine, today announced results from a large randomized controlled trial (RCT), evaluating virtual reality (VR) therapy for treating chronic low back pain (CLBP) at home.

LOS ANGELES, March 21, 2023 /PRNewswire/ -- AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel approach to medicine, today announced that the Centers for Medicare and Medicaid Services (CMS) established a unique Healthcare Common Procedure Coding System (HCPCS) Level II code (E1905) for its flagship product, the RelieVRx program.